12-64466994-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3PP5BS2

The NM_013254.4(TBK1):​c.452C>T​(p.Ser151Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000763 in 1,612,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000084 ( 0 hom. )

Consequence

TBK1
NM_013254.4 missense

Scores

8
7
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:4

Conservation

PhyloP100: 6.05
Variant links:
Genes affected
TBK1 (HGNC:11584): (TANK binding kinase 1) The NF-kappa-B (NFKB) complex of proteins is inhibited by I-kappa-B (IKB) proteins, which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the IKB proteins by IKB kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation and nuclear translocation of the NFKB complex. The protein encoded by this gene is similar to IKB kinases and can mediate NFKB activation in response to certain growth factors. The protein is also an important kinase for antiviral innate immunity response. [provided by RefSeq, Sep 2021]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.776
PP5
Variant 12-64466994-C-T is Pathogenic according to our data. Variant chr12-64466994-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 266068.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=2}.
BS2
High AC in GnomAdExome4 at 122 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBK1NM_013254.4 linkc.452C>T p.Ser151Phe missense_variant Exon 5 of 21 ENST00000331710.10 NP_037386.1 Q9UHD2
TBK1XM_005268809.2 linkc.452C>T p.Ser151Phe missense_variant Exon 5 of 21 XP_005268866.1 Q9UHD2
TBK1XM_005268810.2 linkc.452C>T p.Ser151Phe missense_variant Exon 5 of 21 XP_005268867.1 Q9UHD2
TBK1XR_007063071.1 linkn.551C>T non_coding_transcript_exon_variant Exon 5 of 18

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBK1ENST00000331710.10 linkc.452C>T p.Ser151Phe missense_variant Exon 5 of 21 1 NM_013254.4 ENSP00000329967.5 Q9UHD2

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152118
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000240
AC:
6
AN:
250376
Hom.:
0
AF XY:
0.0000148
AC XY:
2
AN XY:
135400
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000529
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000835
AC:
122
AN:
1460424
Hom.:
0
Cov.:
30
AF XY:
0.0000881
AC XY:
64
AN XY:
726552
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000103
Gnomad4 OTH exome
AF:
0.0000995
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152118
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74306
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000329
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000595

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Motor neuron disease Pathogenic:1
Aug 31, 2016
Centre for Genomic and Experimental Medicine, University of Edinburgh
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: case-control

- -

not specified Uncertain:1
Jan 06, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: TBK1 c.452C>T (p.Ser151Phe) results in a non-conservative amino acid change located in the Protein kinase domain (IPR000719) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 250376 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.452C>T has been reported in the literature in individuals affected with Amyotrophic lateral sclerosis, motor neuron disease, Dementia with Lewy bodies (Cirulli_2015, Black_2017, Orme_2020, Scaber_2023). These reports do not provide unequivocal conclusions about association of the variant with Autoinflammation with arthritis and vasculitis. At least one publication reports experimental evidence evaluating an impact on protein function and this variant affected protein function (Ye_2019). The following publications have been ascertained in the context of this evaluation (PMID: 28089114, 25700176, 25803835, 31996268, 37159497, 31748271). ClinVar contains an entry for this variant (Variation ID: 266068). Based on the evidence outlined above, the variant was classified as uncertain significance. -

TBK1-related disorder Uncertain:1
May 23, 2024
PreventionGenetics, part of Exact Sciences
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

The TBK1 c.452C>T variant is predicted to result in the amino acid substitution p.Ser151Phe. This variant has been reported in a patient with dementia with Lewy bodies and in a patient with motor neuron disease (Table S3 Orme et al. 2020. PubMed ID: 31996268; Table S4 Black. 2017. PubMed ID: 28089114). However, pathogenicity of the c.452C>T variant was not confirmed through additional studies. This variant is reported in 0.0053% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 Uncertain:1
Jul 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 151 of the TBK1 protein (p.Ser151Phe). This variant is present in population databases (rs55824172, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of amyotrophic lateral sclerosis and/or TBK1-related conditions (PMID: 21447600, 28089114, 31996268; Invitae). ClinVar contains an entry for this variant (Variation ID: 266068). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TBK1 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects TBK1 function (PMID: 31748271). This variant disrupts the p.Ser151 amino acid residue in TBK1. Other variant(s) that disrupt this residue have been observed in individuals with TBK1-related conditions (Invitae), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Frontotemporal dementia and/or amyotrophic lateral sclerosis 4;C4693542:Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8;C5935634:Autoinflammation with arthritis and vasculitis Uncertain:1
Sep 15, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Pathogenic
0.19
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Benign
0.29
T
Eigen
Uncertain
0.66
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.91
D
M_CAP
Uncertain
0.098
D
MetaRNN
Pathogenic
0.78
D
MetaSVM
Benign
-0.37
T
MutationAssessor
Benign
1.2
L
PrimateAI
Pathogenic
0.85
D
PROVEAN
Pathogenic
-4.4
D
REVEL
Uncertain
0.50
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.86
MVP
0.79
MPC
1.1
ClinPred
0.92
D
GERP RS
5.2
Varity_R
0.87
gMVP
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs55824172; hg19: chr12-64860774; API